miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.

Saved in:
Bibliographic Details
Title: miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.
Authors: Han, Hu1,2 (AUTHOR), Li, Yan3 (AUTHOR), Qin, Wan1 (AUTHOR), Wang, Lu1 (AUTHOR), Yin, Han1 (AUTHOR), Su, Beibei1 (AUTHOR), Yuan, Xianglin1 (AUTHOR) yuanxianglin@hust.edu.cn
Source: Cancer Cell International. 1/28/2022, Vol. 22 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752867
DOI:10.1186/s12935-022-02460-x